Teva Plans to Sue Dr. Reddy's Over Copaxone Patent Infringement

The filing of the lawsuit will trigger a 30-month stay of FDA approval of Dr. Reddy’s ANDA
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news